• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体(PPAR)γ2基因中Pro12Ala多态性对极度肥胖受试者脂肪组织中PPARγ靶基因表达的影响。

Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.

作者信息

Kolehmainen M, Uusitupa M I J, Alhava E, Laakso M, Vidal H

机构信息

Department of Clinical Nutrition and Food and Health Research Center, University of Kuopio, Finland.

出版信息

J Clin Endocrinol Metab. 2003 Apr;88(4):1717-22. doi: 10.1210/jc.2002-020603.

DOI:10.1210/jc.2002-020603
PMID:12679463
Abstract

The aim was to study the effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue. Adipose tissue samples were collected from 30 massively obese subjects (10 men and 20 women) from omental, sc abdominal, and femoral depots. The mRNA expression of PPARgamma1, PPARgamma2, lipoprotein lipase, p85alpha phosphatidylinositol 3-kinase, and uncoupling protein 2 were quantified by reverse transcription-competitive PCR. The genotypes of Pro12Ala polymorphism were determined by single-strand conformation polymorphism analysis. The frequency of the Ala12 allele was 13.3% (8 Pro12Ala and 22 Pro12Pro). There were no differences in body weight, fat mass, and fasting serum leptin between the genotypes. The mRNA expression of p85alpha phosphatidylinositol 3-kinase was significantly lower in the omental fat of the Pro12Ala carriers than the Pro12Pro carriers (P < 0.01). It also appeared that PPARgamma2 expression was higher in men with Ala12 allele (P < 0.01). Interestingly, particularly in women, the expression of both PPARgamma splice variants was lower in omental than sc fat independently of the genotype (P < 0.05-0.01). The common Pro12Ala polymorphism of the PPARgamma2 gene has minor influence on mRNA expression of PPARgamma target genes in adipose tissue of obese subjects. Expression of both PPARgamma splice variants is dependent on fat depot: omental fat shows lower mRNA levels, compared with sc fat depots.

摘要

目的是研究过氧化物酶体增殖物激活受体(PPAR)γ2基因的Pro12Ala多态性对脂肪组织中PPARγ靶基因表达的影响。从30名极度肥胖受试者(10名男性和20名女性)的网膜、腹部皮下和股部脂肪库采集脂肪组织样本。通过逆转录竞争PCR定量PPARγ1、PPARγ2、脂蛋白脂肪酶、p85α磷脂酰肌醇3激酶和解偶联蛋白2的mRNA表达。通过单链构象多态性分析确定Pro12Ala多态性的基因型。Ala12等位基因的频率为13.3%(8例Pro12Ala和22例Pro12Pro)。不同基因型之间的体重、脂肪量和空腹血清瘦素无差异。Pro12Ala携带者网膜脂肪中p85α磷脂酰肌醇3激酶的mRNA表达显著低于Pro12Pro携带者(P<0.01)。Ala12等位基因的男性中PPARγ2表达似乎也较高(P<0.01)。有趣的是,特别是在女性中,无论基因型如何,网膜脂肪中PPARγ两种剪接变体的表达均低于腹部皮下脂肪(P<0.05-0.01)。PPARγ2基因常见的Pro12Ala多态性对肥胖受试者脂肪组织中PPARγ靶基因的mRNA表达影响较小。PPARγ两种剪接变体的表达均取决于脂肪库:与腹部皮下脂肪库相比,网膜脂肪的mRNA水平较低。

相似文献

1
Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.过氧化物酶体增殖物激活受体(PPAR)γ2基因中Pro12Ala多态性对极度肥胖受试者脂肪组织中PPARγ靶基因表达的影响。
J Clin Endocrinol Metab. 2003 Apr;88(4):1717-22. doi: 10.1210/jc.2002-020603.
2
Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.非糖尿病和2型糖尿病患者中PPAR-γ2基因PRO12ALA多态性与氧化型低密度脂蛋白及心磷脂自身抗体的关联
Metabolism. 2003 Feb;52(2):213-7. doi: 10.1053/meta.2003.50039.
3
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.过氧化物酶体增殖物激活受体基因在人体组织中的表达。肥胖、体重减轻以及胰岛素和糖皮质激素的调节作用。
J Clin Invest. 1997 May 15;99(10):2416-22. doi: 10.1172/JCI119424.
4
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.恒河猴中PPARγ和PPARγ2 mRNA水平与肥胖、糖尿病及高胰岛素血症的关系
Int J Obes Relat Metab Disord. 1998 Oct;22(10):1000-10. doi: 10.1038/sj.ijo.0800718.
5
PPARγ2 Pro12Ala polymorphism is associated with improved lipoprotein lipase functioning in adipose tissue of insulin resistant obese women.过氧化物酶体增殖物激活受体γ2 基因 Pro12Ala 多态性与胰岛素抵抗肥胖女性脂肪组织中脂蛋白脂肪酶功能改善相关。
Gene. 2012 Dec 15;511(2):404-10. doi: 10.1016/j.gene.2012.09.057. Epub 2012 Oct 2.
6
Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.过氧化物酶体增殖物激活受体γ-2基因Pro12Ala多态性对西班牙人群肥胖、胰岛素敏感性和血脂谱的影响。
Eur J Endocrinol. 2002 Oct;147(4):495-501. doi: 10.1530/eje.0.1470495.
7
Depot-specific differences in adipose tissue gene expression in lean and obese subjects.瘦人和肥胖者脂肪组织基因表达的特定储存部位差异。
Diabetes. 1998 Jan;47(1):98-103. doi: 10.2337/diab.47.1.98.
8
Weight loss reduces expression of SREBP1c/ADD1 and PPARgamma2 in adipose tissue of obese women.体重减轻可降低肥胖女性脂肪组织中SREBP1c/ADD1和PPARγ2的表达。
Pflugers Arch. 2001 Jan;441(4):498-505. doi: 10.1007/s004240000454.
9
Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.过氧化物酶体增殖物激活受体γ基因中的两种多态性与肥胖女性的严重超重有关。
J Clin Endocrinol Metab. 1999 Oct;84(10):3708-12. doi: 10.1210/jcem.84.10.6061.
10
[Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].过氧化物酶体增殖物激活受体γ2基因Pro12Ala变异与2型糖尿病的关联
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8.

引用本文的文献

1
Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms.2 型糖尿病成人的代谢生物标志物:PPAR-γ2 和 PPAR-β/δ 多态性的作用。
Biomolecules. 2023 Dec 14;13(12):1791. doi: 10.3390/biom13121791.
2
Peroxisome proliferator-activated receptor γ Pro12 ala polymorphism and risk of cerebral stroke in type 2 diabetes mellitus egyptian patients.2型糖尿病埃及患者中过氧化物酶体增殖物激活受体γ Pro12ala多态性与脑卒中风险
J Diabetes Metab Disord. 2022 Dec 22;22(1):415-422. doi: 10.1007/s40200-022-01159-0. eCollection 2023 Jun.
3
Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
在中国东部人群中,PPARγ、PPARGC1A 和 PPARGC1B 基因变异与胃癌易感性的关联。
BMC Med Genomics. 2022 Dec 31;15(1):274. doi: 10.1186/s12920-022-01428-0.
4
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.过氧化物酶体增殖物激活受体γ(PPARγ)与糖尿病:超越基因组,迈向个体化医学。
Curr Diab Rep. 2021 Apr 18;21(6):18. doi: 10.1007/s11892-021-01385-5.
5
PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study-A Key for Reaching Null Association.载脂蛋白基因 Pro12Ala 多态性与亚洲人群慢性肾脏病的关系:一项荟萃分析合并病例对照研究——达到无关联的关键
Genes (Basel). 2020 Jun 26;11(6):705. doi: 10.3390/genes11060705.
6
The Single Nucleotide Polymorphism Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients.单核苷酸多态性Pro12Ala影响重度肥胖患者的体重指数、脂肪量和血压。
J Obes. 2018 Dec 12;2018:2743081. doi: 10.1155/2018/2743081. eCollection 2018.
7
Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial.膳食多不饱和脂肪酸与PPARG基因Pro12Ala多态性通过不同途径调节血脂:一项随机交叉临床试验
Genes Nutr. 2015 Nov;10(6):43. doi: 10.1007/s12263-015-0493-z. Epub 2015 Oct 7.
8
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.基于药物基因组学的吉西他滨反应特征分析——实现个体化医疗的数据整合框架。
Pharmacogenet Genomics. 2014 Feb;24(2):81-93. doi: 10.1097/FPC.0000000000000015.
9
PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.PPARG:基因表达调控与新一代测序技术解决未决问题
PPAR Res. 2010;2010. doi: 10.1155/2010/409168. Epub 2010 Sep 8.
10
Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm.过氧化物酶体增殖物激活受体 γ 基因多态性、骨保护素与腹主动脉瘤的相关性研究
Clin Endocrinol (Oxf). 2010 Jan;72(1):128-32. doi: 10.1111/j.1365-2265.2009.03615.x. Epub 2009 Apr 25.